Adoptive cellular therapy improves Parkinson’s symptoms in mouse-model study
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
Dr. Daniel Hoh appointed to new leadership role.
Study co-authored by Dr. Karen Hegland found sensorimotor training for airway protection improved cough-related outcomes in Parkinson’s patients.
Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.
UF neurologist Dr. Irene Malaty and international experts publish review on diagnosis and management of functional tic-like phenomena.
Dr. Dawn Bowers and Rachel Schade led study reporting that dopamine medications improves facial movement and expressions in Parkinson’s.
Dr. Jay Clugston and colleagues will lead UF’s research efforts as part of multi-institutional effort.
Drs. Elias Sayour and Daniel Wesson appointed to new leadership roles.
Dr. Emily Fox will lead study evaluating ways to optimize intermittent hypoxia therapy.
Multicenter data sharing has enabled recent advances in understanding the genetics and pathophysiology of the neurodevelopmental disorder.